A 38-year-old woman from Mumbai presents with acute onset epigastric pain and vomiting for 8 hours. She has a 2-year history of recurrent abdominal pain and was recently diagnosed with gallstones on ultrasound. On examination: BP 110/70, HR 95/min, temperature 37.8°C, and mild epigastric tenderness. Laboratory findings: amylase 420 U/L, lipase 580 U/L, ALT 85 U/L, AST 92 U/L, ALP 95 U/L, total bilirubin 1.8 mg/dL, albumin 3.8 g/dL, calcium 9.2 mg/dL. Abdominal ultrasound shows gallstones with a dilated common bile duct (8 mm) and a swollen pancreas. What is the most appropriate immediate management?

Explanation

## Management of Acute Biliary Pancreatitis ### Clinical Context: Mild Pancreatitis with Biliary Etiology **Key Point:** This patient has mild acute pancreatitis (no organ dysfunction, normal calcium, mild enzyme elevation) secondary to gallstones. The management approach differs significantly based on severity and presence of cholangitis. ### Severity Assessment This patient has **mild pancreatitis** because: - No systemic inflammatory response (normal temperature, stable vitals) - No organ dysfunction - Normal serum calcium (9.2 mg/dL) - Mild enzyme elevation - No evidence of necrosis on imaging ### ERCP Timing in Biliary Pancreatitis | Clinical Scenario | ERCP Timing | Rationale | |---|---|---| | **Mild pancreatitis, no cholangitis** | Within 72 hours (or conservative) | Bile duct clearance occurs spontaneously in 80–90% of cases | | **Mild pancreatitis + jaundice/cholangitis** | Within 24 hours (urgent) | Risk of ascending cholangitis and sepsis | | **Severe pancreatitis + cholangitis** | Urgent (<24 hours) | High mortality if untreated; therapeutic intervention needed | | **Severe pancreatitis, no cholangitis** | Delayed (>48 hours) | Avoid worsening inflammation; wait for stabilization | **High-Yield:** Current guidelines (ASGE, ACG) recommend: 1. **Mild pancreatitis without cholangitis:** Supportive care first; ERCP only if jaundice persists or cholangitis develops. 2. **Mild pancreatitis with cholangitis/jaundice:** ERCP within 24 hours. 3. **Severe pancreatitis with cholangitis:** Urgent ERCP. 4. **Severe pancreatitis without cholangitis:** Delay ERCP until clinical improvement. ### Why NOT Immediate ERCP in This Patient? **Clinical Pearl:** This patient does NOT have cholangitis (no fever, no sepsis, no RUQ tenderness). The dilated CBD (8 mm) and mild hyperbilirubinemia (1.8 mg/dL) suggest transient obstruction, which resolves spontaneously in most cases. Performing ERCP in mild pancreatitis increases the risk of: - Post-ERCP pancreatitis (5–10% incidence) - Bleeding and perforation - Unnecessary intervention ### Supportive Care Principles 1. **IV fluid resuscitation:** Goal-directed (urine output 0.5–1 mL/kg/hr) 2. **NPO status:** Until pain resolves and bowel function returns 3. **Analgesia:** Opioids are safe (no increased sphincter pressure with modern agents) 4. **Monitoring:** Serial labs (amylase, lipase), vital signs, organ function 5. **Prophylactic antibiotics:** NOT indicated in mild pancreatitis without signs of infection **Mnemonic:** **SAFE** management of mild biliary pancreatitis: - **S**upportive care (fluids, NPO, analgesia) - **A**void unnecessary ERCP - **F**ollow clinical course - **E**RCP only if cholangitis/jaundice develops ### When to Escalate to ERCP Perform ERCP urgently if: - Persistent jaundice (bilirubin >4 mg/dL) - Signs of cholangitis (fever, RUQ pain, sepsis) - Worsening liver function - Dilated CBD with clinical deterioration ### Definitive Therapy After resolution of acute pancreatitis: - **Cholecystectomy** is indicated (prevents recurrent biliary pancreatitis) - Timing: Laparoscopic cholecystectomy during same admission or within 2 weeks - If ERCP was performed, cholecystectomy should still be done to prevent stone recurrence [cite:Harrison 21e Ch 329; ASGE Guidelines 2020]